1. Home /
  2. Biotechnology

Biotechnology

What Is the Internet of Things and Why Is It Essential in 2019?

What Is the Internet of Things and Why Is It Essential in 2019?

The Internet of Things promises to merge the physical and data worlds together. This is why that's a good thing.

Positive Breadth Helps Momentum Continue Despite Boeing's Woes

Positive Breadth Helps Momentum Continue Despite Boeing's Woes

Strength in Apple and other FANG names are pluses, as are pockets of action in gold mining, cannabis, biotechnology and shipping.

Lannett Rises After Announcing Adderall Distribution Agreement

Lannett Rises After Announcing Adderall Distribution Agreement

Lannett rises after the drugmaker enters an agreement with two other pharmaceutical players to sell a generic form of Adderall.

Exact Sciences Looks Vulnerable: Protect Longs

Exact Sciences Looks Vulnerable: Protect Longs

Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.

Insider Buying Is Still Alive and Well at These 3 Companies

Insider Buying Is Still Alive and Well at These 3 Companies

Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.

Stay Focused on Strong Defense Rather Than New Buys

Stay Focused on Strong Defense Rather Than New Buys

With market sentiment shifting it's time to protect capital until the action improves.

Activists Aim to Eliminate Dual Role for Allergan CEO Saunders

Activists Aim to Eliminate Dual Role for Allergan CEO Saunders

David Tepper's Appaloosa LP renews calls for changes at the top.

I Like the Long Side of Bristol-Myers Squibb

I Like the Long Side of Bristol-Myers Squibb

Let's see what the charts and indicators look like.

Allergan Rises After FDA Accepts License Applications for Botox Supplements

Allergan Rises After FDA Accepts License Applications for Botox Supplements

Allergan wants Botox licenses for pediatric patients.

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.